Platelet-activating factor (PAF), a potent signaling lipid implicated as a mediator of pathological responses, has both negative chronotropic and inotropic effects on the heart, although the mechanism(s) involved is not well defined. Because activation of the muscarinic acetylcholine-activated K' current (IK(ACh)) also produces a negative chronotropic and inotropic response in myocardium, this study examines whether PAF has effects on IK(ACh) in isolated bullfrog atrial myocytes under whole-cell voltage-clamp conditions. We find that 2 ,uM PAF increases the rate of GTP-Y-S-mediated IK (ACh) 
The recent cloning of PAF receptors from guinea pig lung and human leukocytes suggests that PAF receptors are probably coupled to GTP binding proteins (G proteins)14"15 and hence to G protein-mediated signal transduction pathways. In addition, PAF mediates release of vasoactive agents, such as thromboxanes, and a variety of lipoxygenase metabolites of arachidonic acid (AA), including the peptidoleukotrienes. '6-18 There- fore, a variety of the signal transduction pathways that either produce PAF or are activated by PAF are linked to further cellular lipid metabolism. AA metabolites have been linked to activation of KACh in atria.19-21 Therefore, we hypothesized that at least some of the myocardial effects induced by PAF (namely, the decreases in heart rate and cardiac contractility) might be due in part to modulation of KACh activity. In this study, we explore the effect(s) of PAF on muscarinic acetylcholine (ACh)-activated K' current (IK(ACh)) in voltageclamped bullfrog atrial myocytes. We find that PAF modulates the rate of GTP-y-S-mediated lK(ACh) activation via a PAF receptor but that these effects are not mediated by PAF-induced alterations in cellular lipid metabolism.
scribed.21 Briefly, the heart was removed and rinsed with HEPES-buffered Ringer's solution containing (mM) NaCI 90, KCl 2.5, MgCl2 5, CaCl2 2.5, and Na-HEPES 20, pH 7.4. The heart was perfused 5-10 minutes with 25 ml Ca2+-free Ringer's solution containing (mM) NaCl 88.4, KCl 2.5, MgCl2 1.8, NaHCO3 23.8, and NaH2PO4 0.6, supplemented with 2.5 Na-pyruvate, 1 mg/ml fatty acid-free bovine serum albumin, and 1 gl/ml minimal essential medium (MEM) vitamins and essential amino acids. The heart was then perfused for 60 minutes with 25 ml recirculating dissociation solution (Ca2+-free Ringer's solution with 5 mM creatine, 50 units/ml penicillin, and 50 ,ug/ml streptomycin) containing 10 mg trypsin (bovine pancreas, Boehringer Mannheim Corp., Indianapolis, Inc.) and 60 mg collagenase B (Clostridium histolyticum, Boehringer Mannheim). The atrium was dissected in enzyme-free dissociation solution. Single cells were obtained by gentle agitation of the dissected atrium for 30-45 minutes. The cells were then diluted twofold with storage solution (Ca2+-free Ringer's solution with 0.9 mM CaCl2, 5 mM glucose, MEM vitamins and essential amino acids, penicillin, and streptomycin). All solutions were equilibrated at 95% 02-5% CO2 at room temperature (22-24°C) .
Electrophysiology K' currents were recorded with the whole-cell configuration of the patch-clamp technique.22 All experiments were performed within 7 hours of cell isolation at room temperature (22-24°C) . Patch-clamp pipettes (1.0 mm o.d.) were made of square-bore borosilicate tubing (Glass Co. of America, Millville, N.J.) with a FlamingBrown programmable pipette puller (Sutter Instruments Co., San Rafael, Calif.). Ag/AgCI electrodes were used to electrically connect the pipette and bath solutions. Single atrial myocytes were allowed to settle to the bottom of the experimental chamber. Once a highresistance seal was formed, the cell was lifted from the bottom of the chamber and positioned at the mouth of a polyethylene tube, through which bath solutions were continuously superfused at a rate of 1 ml/min. The fast capacitance cancellation was adjusted with the patchclamp amplifier (model EPC-7, List, Darmstadt-Eberstadt, FRG) before breaking the patch. Seal resistance was 1-3 Gfl. Since we monitored the time course of current activation from the instant of patch rupture, we did not compensate for the series resistance (estimated correction at -5 mV was 2-3 mV). The holding potential was -85 mV, and cells were stimulated at 0.8 Hz with 250-msec steps to -125, -85, and -5 mV ( Figure  1A ). Currents were low-pass-filtered at 
GTP-y-S-Mediated Activation of IK(ACh)
KACh can be activated in a receptor-independent manner by intracellular hydrolysis-resistant GTP analogues, such as GTP-y-S. Figure 1A shows typical current tracings at -125 and -5 mV in the absence of ACh (tracing 1, immediately after patch rupture as indicated in Figure 1C) Figure   1B ). Exposure of the cell to ACh activated an additional inwardly rectifying K+ current, IK(ACh) (filled circles in Figure 1B ). The current amplitude recorded at -5 mV is plotted as a function of time (in Figure 1C ) from the time of patch rupture. Since the pipette solution contained GTP-y-S (1.25 mM/0.05 mM GTP), IK(ACh) began to activate in a receptor-independent manner approximately 30 seconds after patch rupture. After approximately 1.2 minutes, 1 ,IM ACh was superfused. The time course of the ACh response displayed the characteristic instantaneous peak current activation followed by an exponential decay (desensitization) to a steadystate current (approximately 70% of the peak current).
The rate of IK(ACh) activation by GTP--y-S was measured as illustrated in Figure 1D (the data of Figure 1C 
Effects of PAF on I'K(Ach) Activation
To test the hypothesis that PAF exerts its effects on myocardium by modulating IK(ACh), we determined whether IK(ACh) was activated by PAF under control conditions (GTP in pipette solution, no ACh). PAF (2 /LM) under these conditions did not significantly activate whole-cell IK(ACh)-We then explored the ability of PAF to modify the GTP-y-S-mediated rate of IK(ACh) activation, as illustrated in the control experiment with ACh in Figure 1C , because this assay is a very sensitive measure of receptor-mediated G protein activation. Addition of 0.2 ,uM PAF increased the GTP-y-Smediated IK(ACh) activation rate by a factor of 4, as illustrated in Figure 2A , and on an expanded time scale, as illustrated in Figure 2B . Before PAF addition, the activation rate was 0.2 min-l; 0.2 ,M PAF resulted in an increase in the rate of IK(ACh) activation to 0.85 min1. concentration of PAF at which the maximal rate is reached could not be assessed, since the critical micellar concentration for PAF (in the absence of bovine serum albumin) has been reported to be less than 5 ,uM in physiological saline solutions. 27, 28 To eliminate the possibility that the effect of PAF was due to nonspecific perturbations of membrane properties, we tested a biologically inactive analogue of PAF (lyso-PAF). Lyso-PAF (2 ,M) did not affect the lK (ACh) activation rate induced by GTP-y-S ( Figure 5A ). The activation rate measured in the presence of 2 ttM lyso-PAF was 0.23 min' ( Figure 5B at -125 mV; data not shown). Inhibition of IKi was reversible and not blocked by a PAF antagonist (CV-3988) or ETYA.
PAF Effects on IK(Ach) Are Receptor Mediated
A PAF receptor from guinea pig lung has been recently cloned and sequenced,15 and on the basis of the hydropathy plot, which contains seven transmembrane segments, it is likely that the PAF receptor is a member of the G protein-coupled receptor family. Since PAF alters the rate of G protein activation (monitored by the rate of GTP-y-S-mediated IK(ACh) activation), we tested whether the effects of PAF could be blocked by the PAF receptor antagonist CV-3988 (a structural analogue of PAF27). CV-3988 did not modify the GTP-y-S-induced activation rate of IK(ACh) when added alone (0.24 min', of several distinct pathways, both G protein dependent and G protein independent. The results of the previous section suggest that a specific PAF receptor mediates the effect of PAF on the IK(ACh) activation rate. To investigate whether all of these effects are G protein-mediated, we tested whether PAF alters steady-state GTP-y-S-activated lK(ACh), since presumably all G protein-mediated pathways are uncoupled from their respective receptors under these conditions. PAF (2 ,uM) had no effect on steady-state GTPy-S-activated lK(ACh) (Figure 7 ), which suggests both that PAF does not activate a distinct K' channel and that G protein-independent lipid metabolic pathways are not involved in PAF-mediated IK(ACh) modulation. In eight cells, the average ACh-induced GTP-y-S-activated steady-state currents before and after PAF addition were not significantly different (129±10 and 139±10 pA, respectively).
AA metabolites are released as a result of PAF stimulation in some cell types. In particular, there are reports that leukotrienes are released from cardiopulmonary elements in response to PAF. 30 (Figure 3 ), supporting the idea that PAF specifically modulates IK(ACh) activation. In addition, the PAF-induced current and that induced by ACh were not additive, since PAF had no effect when lK(ACh) was maximally activated by ACh (Figure 7 ), and ACh had no effect when the PAF-mediated current was maximally activated ( Figure 8C (ACh) activation; this conclusion was based on nordihydroguaiaretic acid-and 4-bromophenacyl bromide-mediated block of the effect of PAF in cell-attached patches (presumably by blocking activation of the 5-lipoxygenase and phospholipase A2-mediated AA release, respectively). Thus, in both bullfrog and guinea pig atrial myocytes, PAF activates IK(ACh) via PAF receptor-mediated activation of G proteins. The divergence of our results in bullfrog atrial myocytes with the results of Nakajima et al13 in the guinea pig can possibly be ascribed to differences in PAF receptor densities in the two species. We do not observe GTP-dependent activation of IK(ACh) by PAF, and as discussed in a previous section, this may be due to a low density of PAF receptors. This low level of PAF receptor may be sufficient to induce an enhanced rate of IK(ACh) activation in the presence of GTP-y-S but not sufficient to induce AA release. Activation of PAF receptors in guinea pig atrial myocytes may induce both activation of Gk and release of AA metabolites, with the predominant effect on IK(ACh) being mediated by AA metabolites (under GTP conditions).
A different mechanism for the negative inotropic effects of PAF on myocardium has been reported in rat ventricular tissue, which does not express IK(ACh).33 This mechanism involves specific PAF receptor-mediated stimulation of protein kinase C via the phospholipase C/phosphatidylinositol signaling pathway, with subsequent loss of contractile force. A variety of PAF receptor-mediated mechanisms thus make up the complex myocardial response to PAF.
In conclusion, PAF can modulate IK(ACh) activity in bullfrog atrial myocytes. The mechanism of PAF action is analogous to ACh in that PAF binds to its receptor, which is coupled to a G protein (possibly Gk), which in turn activates KACh channels. This mechanism may contribute to the overall inotropic action of PAF by "sensitizing" the mAChR-mediated signal transduction pathway.
